The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers.
about
High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma.Farnesyl phenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense.Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers.A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent anti-tumor activity.The absence of a novel intron 19-retaining ALK transcript (ALK-I19) and MYCN amplification correlates with an excellent clinical outcome in neuroblastoma patients.
P2860
The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The use of cellular thermal sh ...... ALK-expressing human cancers.
@en
type
label
The use of cellular thermal sh ...... ALK-expressing human cancers.
@en
prefLabel
The use of cellular thermal sh ...... ALK-expressing human cancers.
@en
P2093
P2860
P356
P1433
P1476
The use of cellular thermal sh ...... n ALK-expressing human cancers
@en
P2093
Abdulraheem Alshareef
Ahmed El-Sehemy
Chengsheng Wu
Hai-Feng Zhang
Jing Dong Zhang
Raymond Lai
P2860
P2888
P356
10.1038/SREP33710
P407
P577
2016-09-19T00:00:00Z